Abstract

INDIAN PHARMACEUTICAL STRATEGIES FOR GLOBAL EXPANSION

Sukri Suryam* and P. Bala Krishnaiah

ABSTRACT

India is the largest supplier of generic drugs globally. The Indian pharmaceutical industry has established a major supplier of not only generic drugs but also new formulations. Indian companies are key players in the global generic markets and face many challenges and offer a wide range of opportunities for the pharmaceutical companies. The Indian pharmaceutical industry develops different type of strategies are collaborative strategies, business strategies and over corporate growth strategies. The TRIPS have the greatest impact on the pharmaceutical sector and maintain standards for protecting and enforcing all forms of intellectual property rights. Before drug approval, pharmaceutical companies has different acts i.e., national pharmaceutical pricing policy, compulsory licensing, drug approval and ANDA filling process, companies act, competition act and foreign exchange management act. Natco pharma has adopted a number of regulatory strategies to get its foothold in the oncology sector. Natco pharma focused on R&D, vertically integrated pharmaceutical company engaged in the development, manufacture and marketing of finished dosage form.India emerged as one of the fast growing pharmaceutical industry in the world with growing trade surpluses and exports. It is employed its technical and legal skills to get into a dominating position in the generic market of india and of the world.

Keywords: Challenges, Growth strategy, Regulation of pharmaceutical industry, Natco pharma.